Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02317705 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
A Phase 2 study, sponsored by On Target Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT02317705: Completed Phase 2 study, sponsored by On Target Laboratories.
NCT02317705 is a Phase 2 study that has completed, run by On Target Laboratories. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02317705, a Phase 2 study, has completed, sponsored by On Target Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study is being done to: * test the safety of OTL38 * see if OTL38 helps light up the cancer when viewed with the special camera system * test the safety of the special camera system for use along with OTL38 during surgery
Interventions
- PROCEDURE Laparotomy
- DEVICE Near infrared camera imaging system
- DRUG OTL38
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02317705
The ClinicalTrials.gov registry entry for NCT02317705 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is On Target Laboratories, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laparotomy is the first listed.
NCT02317705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02317705 about?
NCT02317705 is a clinical study titled "Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer". This study is being done to: * test the safety of OTL38 * see if OTL38 helps light up the cancer when viewed with the special camera system * test the safety of the special camera system for use along with OTL38 during surgery
What is the current status of trial NCT02317705?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2014-12. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02317705?
The interventions under investigation include: Laparotomy (PROCEDURE), Near infrared camera imaging system (DEVICE), OTL38 (DRUG).
Who is sponsoring clinical trial NCT02317705?
This trial is sponsored by On Target Laboratories, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.